NUWE Company Profile and Key Details

Q: Who are the executives of NUWE?

Mr. Laurent DuhouxVice President of International Bus. Devel.Mr. Rob ScottSenior Director of Financial Planning & Analysis and Interim Principal Accounting OfficerMr. William Colon M.D.Vice President of MarketingDr. John Lynn Jefferies FACC, M.D., M.P.H.Chief Medical Officer & Member of Medical Advisory BoardMr. Vitaliy EpshteynSenior Vice President of Operations & EngineeringMr. Nestor Jaramillo Jr.Pres, Chief Executive Officer & DirectorMs. Lynn L. Blake CPA, M.B.A.Chief Financial OfficerMr. Neil P. Ayotte Esq.Senior Vice President, Gen. Counsel, Sec. & Chief Compliance OfficerMr. John KowalczykSenior Vice President of Sales & MarketingMs. Sandra EayrsChief HR OfficerMr. Paul WottaCorporation Controller

NASDAQ : NUWE

Nuwellis

$0.17

-0.2638-61.21%

Open: 4:00 PM

65.11

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Nuwellis, Inc. (NUWE) stock declined over -61.21%, trading at $0.17 on NASDAQ, down from the previous close of $0.43. The stock opened at $0.17, fluctuating between $0.15 and $0.21 in the recent session.

Stock Snapshot

0.431

Prev. Close

150.93K

Market Cap

0.1472

Day Low

-0.01

P/E Ratio

-26.89

EPS (TTM)

-5.14

Cash Flow per Share

0.17

Open

902.67K

Number of Shares

0.2083

Day High

66.74%

Free Float in %

0.84

Book Value

48.02M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jun 05, 2026	0.17	0.21	0.15	0.17	48.84M
Jun 04, 2026	0.48	0.51	0.40	0.43	563.22K
Jun 03, 2026	0.60	0.61	0.48	0.49	474.89K
Jun 01, 2026	0.73	0.80	0.70	0.70	280.72K
May 29, 2026	0.83	0.86	0.75	0.77	317.27K
May 28, 2026	0.74	0.99	0.73	0.85	632.83K
May 27, 2026	0.91	0.93	0.75	0.76	231.59K
May 26, 2026	0.90	0.99	0.89	0.91	245.65K
May 22, 2026	1.00	1.05	0.96	1.05	111.58K
May 21, 2026	0.95	1.00	0.95	1.00	19.4K
May 20, 2026	0.98	0.99	0.95	0.99	14.39K
May 19, 2026	0.97	0.98	0.93	0.98	15.33K
May 18, 2026	0.98	1.00	0.90	0.98	115.39K
May 15, 2026	1.03	1.08	0.98	1.00	54.28K
May 14, 2026	1.07	1.12	1.00	1.02	120.24K
May 13, 2026	1.06	1.06	0.99	1.03	27.1K
May 12, 2026	1.06	1.06	1.00	1.03	45.85K
May 11, 2026	1.07	1.08	1.00	1.04	51.13K
May 08, 2026	1.08	1.11	1.07	1.09	26.71K
May 07, 2026	1.09	1.10	1.06	1.10	29.45K

Contact Details

Eden Prairie, MN 55344

United States

https://www.nuwellis.com 952 345 4200

About Company

Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex FlexFlow system includes a console, disposable blood set, and catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors primarily in Austria, Brazil, Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Stock Peers

BRKRP

-39.44-8.56%

Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A$421.23 SWAV

-0.08-0.02%

ShockWave Medical, Inc.$334.75 UFPT

-0.635-0.28%

UFP Technologies, Inc.$223.87 ALGN

-0.55-0.33%

Align Technology, Inc.$167.74 PODD

6.81+4.65%

Insulet Corporation$153.22 IRTC

0.755+0.70%

iRhythm Technologies, Inc.$108.11 IRMD

-0.5-0.53%

IRadimed Corporation$93.07 NARI

Inari Medical, Inc.$79.97 ESTA

-2.18-2.85%

Establishment Labs Holdings Inc.$74.31 DXCM

0.27+0.37%

DexCom, Inc.$72.86

Company Overview

Nuwellis, Inc. (NASDAQ:NUWE) closed at $0.17 USD, losing -$0.26 (-61.21%) from the previous close of $0.43. The stock is currently mid-range between its 52-week high and low $0.15 and $32.76. With a market capitalization of about $150.93 thousand, Nuwellis, Inc. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.19). Key stats such as the average daily volume over the past year has been around 96.55 thousand shares, trading with heavier-than-usual volume. Headquartered in Eden Prairie, MN, Nuwellis, Inc. operates in the Healthcare sector and the Medical - Devices industry. Led by CEO John L. Erb, the company employs approximately 38 people and listed since February 16, 2012. Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy.

Technical Performance

Short-term trend indicators are mixed aligned (SMA20 -35.03%, SMA50 -29.6%, SMA200 -79.58%). The stock’s 14-day RSI is 35.59 (weak momentum), while the ATR of 0.33 points to higher daily volatility. The stock remains sitting in the mid-range of its 52-week band, trading -97.16% below its high and over 0.0% above its low. Average 10-day trading volume of 7.33 million shares is significantly above the 3-month average of 929.15 thousand, indicating heightened recent market interest.

Valuation Metrics

Nuwellis, Inc. trades at a P/E ratio of -0.02, slightly below the S&P 500 average, with a price-to-sales ratio of 0.02 and a price-to-book ratio of 0.12 suggesting the stock is closer to book value. The P/FCF stands at -0.01, also above market averages.

Dividend & Fair Value

Nuwellis, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.05. This means the shares are trading below this model’s fair value.

Earnings & Analyst Outlook

Nuwellis, Inc. generated EPS of -$107.66 over the past year. Five-year average earnings growth is 90.39%. Wall Street analysts project EPS growth of 85.85% annually over the next five years. The latest quarter delivered EPS of -$2.09. The next quarter is forecast at -$1.56. Next year's EPS is expected at $68.03. Nuwellis, Inc. earnings surprise history is a mixed track record. The quarter that ended May 12, 2026, missed forecasts by 109.0%. The prior quarter beat by -3.85%. Over the last six quarters, Apple has recorded several small beats. These include 51.16% in March 11, 2025.

Shareholding & Insider Activity

Nuwellis, Inc. has 902.66 thousand shares outstanding. The public float is 876.13 thousand shares, elevated short interest at 3.01% of float. This equals 26.34 thousand shares. The short ratio is 0.01 days. Institutional investors hold 1.54% of the float. Insiders own 2.92%. Choi Ki Yong holds 1.79 million shares, BUCKMAN PAUL has 24.01 thousand shares and MATHIESEN JEFFREY S has 20.02 thousand shares.

Financial & Profitability Overview

Over the trailing twelve months, Nuwellis generated $8.86M in revenue, or $4.51 per share. Gross margin was 56.22%, operating margin -198.89%, and net profit margin -227.99%. Returns are negative, with ROA at -206.85% and ROE at -675.89%.
On valuation metrics, Nuwellis trades at a P/E of -0.02, P/S of 0.02 and P/B of 0.12. The current ratio is 1.56 and quick ratio is 1.09. Operationally, the company’s inventory turnover is 1.70 and cash conversion cycle is -13.46 days , indicating it collects cash faster than it pays suppliers. Debt-to-equity is 0.09, supported by a cash flow-to-debt ratio of -42.97.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Nuwellis posted revenue of $8.86M, down slightly from $8.54M in the prior quarter. Gross profit was $4.98M (margin 56.22%). Operating income was - $17.63M (margin -198.9%). Net income was- $20.21M (EPS - $10.29).
The company ended the quarter with $3.80M in cash and short-term investments, a total debt of $981.00K, and net debt of - $2.82M. Total assets were $9.77M, with equity of $2.99M. Financials further reflected weakness, with operating cash flow of - $17.94M, free cash flow of - $18.19M, and capital expenditures of - $248.00K.

Price Forecast & Outlook

Our AI price prediction model suggests that Nuwellis, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -100.0%, with price expected at $0.00 by June 19, 2026, within a range of $0.00 to $0.00 3-Month Outlook: Projected fall of -28.23%, reaching $0.12 by September 03, 2026, with a range of $0.00 to $1.50. 1-Year Outlook: Projected loss of -94.02%, with price at $0.01 by June 04, 2027, within a range of $0.00 to $28.89.

Key Takeaways

Nuwellis, Inc. (NASDAQ:NUWE) shares are flat 5.17% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Nuwellis, Inc. trading at a premium to the broader market with a P/E of -0.02. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $17.00, suggesting 10067.46% upside. Our AI forecast model points to short-term weakness (-100.0% over two weeks), a medium-term fall (-28.23% over three months), and a longer-term loss (-94.02% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Nuwellis, Inc. (NUWE) stock price?

Nuwellis, Inc. (NASDAQ: NUWE) stock price is $0.17 in the last trading session. During the trading session, NUWE stock reached the peak price of $0.21 while $0.15 was the lowest point it dropped to. The percentage change in NUWE stock occurred in the recent session was -61.21% while the dollar amount for the price change in NUWE stock was - $0.26.

NUWE's industry and sector of operation?

The NASDAQ listed NUWE is part of Medical - Devices industry that operates in the broader Healthcare sector. Nuwellis, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NUWE?

Mr. Laurent Duhoux
Vice President of International Bus. Devel.
Mr. Rob Scott
Senior Director of Financial Planning & Analysis and Interim Principal Accounting Officer
Mr. William Colon M.D.
Vice President of Marketing
Dr. John Lynn Jefferies FACC, M.D., M.P.H.
Chief Medical Officer & Member of Medical Advisory Board
Mr. Vitaliy Epshteyn
Senior Vice President of Operations & Engineering
Mr. Nestor Jaramillo Jr.
Pres, Chief Executive Officer & Director
Ms. Lynn L. Blake CPA, M.B.A.
Chief Financial Officer
Mr. Neil P. Ayotte Esq.
Senior Vice President, Gen. Counsel, Sec. & Chief Compliance Officer
Mr. John Kowalczyk
Senior Vice President of Sales & Marketing
Ms. Sandra Eayrs
Chief HR Officer
Mr. Paul Wotta
Corporation Controller

How NUWE did perform over past 52-week?

NUWE's closing price is 13.59% higher than its 52-week low of $0.15 where as its distance from 52-week high of $32.76 is -99.49%.

How many employees does NUWE have?

Number of NUWE employees currently stands at 38.

Link for NUWE official website?

Official Website of NUWE is: https://www.nuwellis.com

How do I contact NUWE?

NUWE could be contacted at phone 952 345 4200 and can also be accessed through its website. NUWE operates from 12988 Valley View Road, Eden Prairie, MN 55344, United States.

How many shares of NUWE are traded daily?

NUWE stock volume for the day was 48.02M shares. The average number of NUWE shares traded daily for last 3 months was 96.55K.

What is the market cap of NUWE currently?

The market value of NUWE currently stands at $150.93K with its latest stock price at $0.17 and 902.67K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	38
Beta	-0.01
Sales or Revenue	$8.86M
5Y Sales Change%	-1%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Medical - Devices

NUWE Company Profile and Key Details

Nuwellis

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Price Forecast & Outlook

Key Takeaways

Financial & Profitability Overview

Quarterly Financial Highlights